Cart
sales@molnova.com
Phenylphosphinic acid
CAS No. 1779-48-2
Phenylphosphinic acid( NSC 2670 | NSC-2670 | NSC2670 )
Catalog No. M27267 CAS No. 1779-48-2
Phenylphosphinic acid is an additive used with Noyori's catalyst and improves the flame retardancy of poly(lactic acid).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 10MG | 63 | In Stock |
|
| 25MG | 103 | In Stock |
|
| 50MG | 150 | In Stock |
|
| 100MG | 223 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 482 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePhenylphosphinic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhenylphosphinic acid is an additive used with Noyori's catalyst and improves the flame retardancy of poly(lactic acid).
-
DescriptionPhenylphosphinic acid is an additive used with Noyori's catalyst and improves the flame retardancy of poly(lactic acid). Phenylphosphinic acid can be used for oxidation of sulfides to sulfones.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC 2670 | NSC-2670 | NSC2670
-
PathwayOthers
-
TargetOther Targets
-
RecptorMALT1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1779-48-2
-
Formula Weight142.094
-
Molecular FormulaC6H7O2P
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOP(=O)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Virtual meeting delivers first time drug structures
molnova catalog
related products
-
Neuropeptide AF (93-...
Neuropeptide AF (93-110), Human is an endogenous antiopioid peptide.
-
Trimethoprim lactate
Trimethoprim lactic is a bacteriostatic antibiotic and an orally active dihydrofolate reductase inhibitor. Trimethoprim lactic is active against a wide range of Gram-positive and Gram-negative aerobic bacteria .
-
Physalin O
Physalin O possesses anti-inflammatory activity, it exhibited conjugating abilities with GSH and also showed significant nitric oxide (NO) production inhibiting activities.
